Vanguard Fiduciary Trust’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Sell
848,468
-41,468
-5% -$4.51M 0.03% 462
2026
Q1
$82.2M Buy
+889,936
New +$89.4M 0.02% 586

Other funds holding GH

Vanguard Fiduciary Trust's GH Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Guardant Health (GH) stake by 4.7% in Q2 2026, selling an estimated $4.51M and leaving 848,468 shares worth $127M. The position accounts for 0.03% of the portfolio, ranked #462.

Vanguard Fiduciary Trust first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 594 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Vanguard Fiduciary Trust held 848,468 shares of Guardant Health worth $127M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 41,468 Guardant Health shares in Q2 2026, an estimated $4.51M.
  • Guardant Health made up 0.03% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #462 holding.
  • Vanguard Fiduciary Trust first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
  • 594 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.